Stopped: Company decision not related to safety.
Many drugs used for the treatment of Type 2 Diabetes Mellitus cause the body to retain water. This study will assess whether or not GW677954 causes the body to retain fluid.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
changes in fluid related parameters as measured by hematocrit and hemoglobin levels and body weight
Timeframe: up to 24 weeks